MADISON, N.J. Feb. 1, 2011 $56.25
Quest Diagnostics has not sold any shares of common stock in the offering and will not receive any of the proceeds from the sale of shares in the offering.
Deutsche Bank Securities Inc. and J.P. Morgan Securities LLC are joint bookrunners for the offering.
Jersey City, N.J. Edgewood, NY
About Quest Diagnostics
Quest Diagnostics is the world’s leading provider of diagnostic testing, information and services that patients and doctors need to make better healthcare decisions. The company offers the broadest access to diagnostic testing services through its network of laboratories and patient service centers, and provides interpretive consultation through its extensive medical and scientific staff. Quest Diagnostics is a pioneer in developing innovative diagnostic tests and advanced healthcare information technology solutions that help improve patient care.
Kathleen Valentine Gary Samuels
SOURCE Quest Diagnostics Incorporated